Analysis of Small Molecule Drugs, Metabolites and Biomarkers
Celerion has 40 years experience in traditional small molecule, metabolite, biomarker and peptide bioanalysis. The work is performed using LC-MS/MS in our Lincoln, Nebraska and Zurich, Switzerland facilities with HPLC, UPLC or TurboFlow techniques. Sciclone, Tecan and Tomtec robotic systems are involved in the methods development stage to enhance method reproducibility and sample throughput. Immunoanalytical techniques such as ELISA, ECLA and RIA can also be very helpful in specific small molecule and biomarker methods.
The team’s experience in the LC-MS/MS analysis of endogenous biomarkers, their congeners and metabolites such as leukotrienes, prostaglandins, peptides, steroids and other compounds provides certainty that, however complex the bioanalytical challenge, Celerion will help clients achieve an excellent study outcome.
With over 35 LC-MS/MS instruments and several immunoassay platforms available for methods development, validation and sample analysis, Celerion has the capacity and expertise to meet and exceed study timelines.